Bio-Rad Laboratories (BIO) Non-Current Debt (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Non-Current Debt data on file, last reported at $802.9 million in Q1 2026.

• On a quarterly basis, Non-Current Debt fell 33.13% year-over-year to $802.9 million in Q1 2026; TTM through Mar 2026 was $802.9 million, a 33.13% decrease from a year earlier, with the FY2025 full-year figure at $1.2 billion, changed 0.11% from the prior year.
• Non-Current Debt for Q1 2026 stood at $802.9 million, down from $1.2 billion in the prior quarter.
• Over the last five years, Non-Current Debt for BIO reached as high as $1.2 billion in Q3 2025 and fell as low as $395.7 million in Q1 2022.
• Historically, Non-Current Debt has averaged $1.1 billion across 5 years, with a median of $1.2 billion in 2023.
• Across the five-year window, Non-Current Debt surged 11291.63% in 2022 and slumped 33.13% in 2026, its largest moves.
• Year by year, Non-Current Debt stood at $1.2 billion in 2022, then climbed by 0.12% to $1.2 billion in 2023, then rose by 0.11% to $1.2 billion in 2024, then rose by 0.11% to $1.2 billion in 2025, then plunged by 33.19% to $802.9 million in 2026.
• Per Business Quant data, the three most recent Non-Current Debt figures were $802.9 million in Q1 2026, $1.2 billion in Q4 2025, and $1.2 billion in Q3 2025.